(Q46184908)

20 December 2017

title

Use of prostate-specific antigen in the follow-up of patients with localized prostate cancer: results of a nationwide survey of urologists (English)

1 reference

20 December 2017

David Penson

1

0 references

author name string

Judd Moul

series ordinal

2

1 reference

20 December 2017

Sanjay Gandhi

series ordinal

3

1 reference

20 December 2017

Don Newling

series ordinal

4

1 reference

20 December 2017

language of work or name

English

0 references

publication date

13 June 2006

1 reference

20 December 2017

published in

Urology

1 reference

20 December 2017

volume

68

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

80-84

1 reference

20 December 2017

Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

Natural history of progression after PSA elevation following radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

A perfect correlate does not a surrogate make

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

Initiation of salvage therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

Prostate-specific antigen doubling times are similar in patients with recurrence after radical prostatectomy or radiotherapy: a novel analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

PSAdynia and other PSA-related syndromes: a new epidemic--a case history and taxonomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.028

10.1016/J.UROLOGY.2006.01.028

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017